Protection from angiotensin II–mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ

Carmine Vecchione, Enrico Patrucco(University of Turin), Gennaro Marino, Laura Barberis(University of Turin), Roberta Poulet, Alessandra Aretini, Angelo Maffei, Maria Teresa Gentile, Marianna Storto, Ornella Azzolino(University of Turin), Mara Brancaccio(University of Turin), GianLuca Colussi, Umberto Bettarini, Fiorella Altruda(University of Turin), Lorenzo Silengo(University of Turin), Guido Tarone(University of Turin), Matthias P. Wymann(University of Basel), Emilio Hirsch(University of Turin), Giuseppe Lembo(Sapienza University of Rome)
The Journal of Experimental Medicine
April 11, 2005
Cited by 141Open Access
Full Text

Abstract

Hypertension affects nearly 20% of the population in Western countries and strongly increases the risk for cardiovascular diseases. In the pathogenesis of hypertension, the vasoactive peptide of the renin-angiotensin system, angiotensin II and its G protein-coupled receptors (GPCRs), play a crucial role by eliciting reactive oxygen species (ROS) and mediating vessel contractility. Here we show that mice lacking the GPCR-activated phosphoinositide 3-kinase (PI3K)gamma are protected from hypertension that is induced by administration of angiotensin II in vivo. PI3Kgamma was found to play a role in angiotensin II-evoked smooth muscle contraction in two crucial, distinct signaling pathways. In response to angiotensin II, PI3Kgamma was required for the activation of Rac and the subsequent triggering of ROS production. Conversely, PI3Kgamma was necessary to activate protein kinase B/Akt, which, in turn, enhanced L-type Ca(2+) channel-mediated extracellular Ca(2+) entry. These data indicate that PI3Kgamma is a key transducer of the intracellular signals that are evoked by angiotensin II and suggest that blocking PI3Kgamma function might be exploited to improve therapeutic intervention on hypertension.


Related Papers